Follow
Dr. Anuraj Nayarisseri
Dr. Anuraj Nayarisseri
Principal Scientist, Eminent Biosciences, Indore - India.
Verified email at eminentbio.com - Homepage
Title
Cited by
Cited by
Year
Screening, isolation and characterization of biosurfactant producing Bacillus subtilis strain ANSKLAB03
A Nayarisseri, P Singh, SK Singh
Bioinformation 14 (6), 304, 2018
1222018
Implications of a novel Pseudomonas species on low density polyethylene biodegradation: an in vitro to in silico approach
M Bhatia, A Girdhar, A Tiwari, A Nayarisseri
SpringerPlus 3, 1-10, 2014
1082014
Computational studies applied to flavonoids against Alzheimer’s and Parkinson’s diseases
AFM Monteiro, JDO Viana, A Nayarisseri, EN Zondegoumba, ...
Oxidative medicine and cellular longevity 2018, 2018
752018
Artificial intelligence, big data and machine learning approaches in precision medicine & drug discovery
A Nayarisseri, R Khandelwal, P Tanwar, M Madhavi, D Sharma, G Thakur, ...
Current drug targets 22 (6), 631-655, 2021
672021
Structure-based virtual screening for the identification of high affinity compounds as potent VEGFR2 inhibitors for the treatment of renal cell carcinoma
K Sharma, K Patidar, MA Ali, P Patil, H Goud, T Hussain, A Nayarisseri, ...
Current topics in medicinal chemistry 18 (25), 2174-2185, 2018
442018
An In silico Approach to Identify High Affinity Small Molecule Targeting m-TOR Inhibitors for the Clinical Treatment of Breast Cancer
K Patidar, U Panwar, S Vuree, J Sweta, MK Sandhu, A Nayarisseri, ...
Asian Pacific Journal of Cancer Prevention 20 (4), 1229-1241, 2019
402019
Virtual screening approaches in identification of bioactive compounds Akin to delphinidin as potential HER2 inhibitors for the treatment of breast cancer
K Patidar, A Deshmukh, S Bandaru, C Lakkaraju, A Girdhar, G Vr, ...
Asian Pacific Journal of Cancer Prevention 17 (4), 2291-2295, 2016
402016
Molecular dynamic simulations reveal suboptimal binding of salbutamol in T164I variant of β2 adrenergic receptor
S Bandaru, M Alvala, A Nayarisseri, S Sharda, H Goud, HP Mundluru, ...
PloS one 12 (10), e0186666, 2017
392017
Screening, isolation and characterization of biosurfactant-producing Bacillus tequilensis strain ANSKLAB04 from brackish river water
A Nayarisseri, P Singh, SK Singh
International journal of environmental science and technology 16 (11), 7103-7112, 2019
382019
Shape-based machine learning models for the potential novel COVID-19 protease inhibitors assisted by molecular dynamics simulation
A Nayarisseri, R Khandelwal, M Madhavi, C Selvaraj, U Panwar, ...
Current topics in medicinal chemistry 20 (24), 2146-2167, 2020
372020
A virtual screening approach for the identification of high affinity small molecules targeting BCR-ABL1 inhibitors for the treatment of chronic myeloid leukemia
S Sharda, P Sarmandal, S Cherukommu, K Dindhoria, M Yadav, ...
Current topics in medicinal chemistry 17 (26), 2989-2996, 2017
372017
An in silico investigation of potential EGFR inhibitors for the clinical treatment of colorectal cancer
M Majhi, MA Ali, A Limaye, K Sinha, P Bairagi, M Chouksey, R Shukla, ...
Current topics in medicinal chemistry 18 (27), 2355-2366, 2018
362018
Molecular Docking studies of FKBP12-mTOR inhibitors using binding predictions
AB Nasr, D Ponnala, SR Sagurthi, RK Kattamuri, VK Marri, S Gudala, ...
Bioinformation 11 (6), 307, 2015
362015
Molecular docking based screening of GABA (A) receptor inhibitors from plant derivatives
MM Sahila, PP Babitha, S Bandaru, A Nayarisseri, VA Doss
Bioinformation 11 (6), 280, 2015
362015
High affinity pharmacological profiling of dual inhibitors targeting RET and VEGFR2 in inhibition of kinase and angiogeneis events in medullary thyroid carcinoma
NR Dunna, V Kandula, A Girdhar, A Pudutha, T Hussain, S Bandaru, ...
Asian Pacific Journal of Cancer Prevention 16 (16), 7089-7095, 2015
352015
Molecular Docking and pharmacological investigations of rivastigmine-fluoxetine and coumarin–tacrine hybrids against acetyl choline esterase
PP Babitha, MM Sahila, S Bandaru, A Nayarisseri, S Sureshkumar
Bioinformation 11 (8), 378, 2015
342015
An in silico approach for identification of novel inhibitors as a potential therapeutics targeting HIV-1 viral infectivity factor
C Sinha, A Nischal, S Bandaru, P Kasera, A Rajput, A Nayarisseri, ...
Current Topics in Medicinal Chemistry 15 (1), 65-72, 2015
342015
Molecular docking approaches in identification of High affinity inhibitors of Human SMO receptor
UR Akare, S Bandaru, U Shaheen, PK Singh, G Tiwari, P Singare, ...
Bioinformation 10 (12), 737, 2014
332014
Design of PD-L1 inhibitors for lung cancer
SKS Trishang Udhwani, Sourav Mukherjee, Khushboo Sharma, Jajoriya Sweta ...
Bioinformation 15 (2), 139-150, 2019
32*2019
Design of novel JAK3 Inhibitors towards Rheumatoid Arthritis using molecular docking analysis
SKS Divya Jain, Trishang Udhwani, Shreshtha Sharma, Aishwarya Gandhe ...
Bioinformation 15 (2), 68-78, 2019
322019
The system can't perform the operation now. Try again later.
Articles 1–20